✦ LIBER ✦

Portosystemic shunts in a large cohort of patients with liver cirrhosis: detection rate and clinical relevance

✍ Scribed by Enrico Maria Zardi; Valentina Uwechie; Domenico Caccavo; Nelly Maria Pellegrino; Fabio Cacciapaglia; Francesco Di Matteo; Aldo Dobrina; Vittorio Laghi; Antonella Afeltra

Publisher: Springer Japan
Year: 2009
Tongue: English
Weight: 295 KB
Volume: 44
Category: Article
ISSN: 0944-1174
DOI: 10.1007/s00535-008-2279-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk of liver and other types of cancer

Risk of liver and other types of cancer in patients with cirrhosis: A nationwide cohort study in Denmark

✍ Dr. Henrik Toft Sørensen; Søren Friis; Jørgen H. Olsen; Ane Marie Thulstrup; Len 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB 👁 1 views

Cancer risk in patients with cirrhosis could be modified by factors such as changes in hormonal levels, impaired metabolism of carcinogens, or alteration of immunological status. We investigated the risk of liver and various forms of cancer in patients with cirrhosis in a follow-up study. We identif

A clinical and genetic study in a large

A clinical and genetic study in a large cohort of patients with spinocerebellar ataxia type 6

✍ Hiroki Takahashi; Kinya Ishikawa; Takeshi Tsutsumi; Hiroto Fujigasaki; Akihiro K 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 237 KB

Characterization and clinical relevance

Characterization and clinical relevance of a new complement-fixing antibod–anti-m8–in patients with primary biliary cirrhosis

✍ Paul Weber; Judith Brenner; Ernst Stechemesser; Reinhild Klein; Ulrike Weckenman 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 735 KB

A new complement-fixing antimitochondrial antibody--anti-M8--was detected in patients with primary biliary cirrhosis. Anti-M8 was only found in association with anti-M2, however, not all anti-M2 positive patients had anti-M8. Thus, among 66 anti-M2 positive patients, 29 were also positive for anti-M

A clinical, genetic, and biochemical cha

A clinical, genetic, and biochemical characterization of SPG7 mutations in a large cohort of patients with hereditary spastic paraplegia

✍ Alessia Arnoldi; Alessandra Tonelli; Francesca Crippa; Gaetano Villani; Consigli 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 471 KB 👁 1 views

Mutations in the SPG7 gene encoding a mitochondrial protein termed paraplegin, are responsible for a recessive form of hereditary spastic paraparesis. Only few studies have so far been performed in large groups of hereditary spastic paraplegia (HSP) patients to determine the frequency of SPG7 mutati

Prevalence, kinetics, and therapeutic mo

Prevalence, kinetics, and therapeutic modulation of autoantibodies against Sp100 and promyelocytic leukemia protein in a large cohort of patients with primary biliary cirrhosis

✍ D Züchner; T Sternsdorf; C Szostecki; E J Heathcote; K Cauch-Dudek; H Will 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 617 KB

Antinuclear antibodies (ANA) staining nuclear dot structures predominantly occur in primary biliary cirrhosis (PBC) patients and recognize the Sp100 and promyelocytic leukemia protein (PML). From retrospective analysis of sera from a clinically well-defined Canadian series of 170 PBC patients includ

Sclerotherapy vs. esophageal transection

Sclerotherapy vs. esophageal transection vs. distal splenorenal shunt for the clinical management of esophageal varices in patients with child class A and B liver function: A prospective randomized trial

✍ Seigo Kitano; Yasunori Iso; Makoto Hashizume; Hirohiko Yamaga; Nobuhiro Koyanagi 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 691 KB

Ninety-six patients with good liver function (Child class A or B) and esophageal varices were randomly assigned to one of three groups given different treatments: endoscopic injection sclerotherapy (n = 32), esophageal transection (n = 32) or distal splenorenal shunt (n = 32). Five patients (5.2%) h